KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Globus Medical (GMED) Receivables Refunds (2016 - 2026)

Globus Medical filings provide 15 years of Receivables Refunds readings, the most recent being $64.7 million for Q4 2025.

  • On a quarterly basis, Receivables Refunds rose 213.71% to $64.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $64.7 million, a 213.71% increase, with the full-year FY2025 number at $64.7 million, up 213.71% from a year prior.
  • Receivables Refunds hit $64.7 million in Q4 2025 for Globus Medical, down from $69.0 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $69.0 million in Q3 2025 to a low of $366000.0 in Q1 2024.
  • Median Receivables Refunds over the past 5 years was $3.3 million (2022), compared with a mean of $13.9 million.
  • Biggest five-year swings in Receivables Refunds: skyrocketed 2043.21% in 2021 and later tumbled 87.97% in 2024.
  • Globus Medical's Receivables Refunds stood at $1.2 million in 2021, then surged by 234.24% to $4.1 million in 2022, then plummeted by 59.74% to $1.6 million in 2023, then surged by 1161.96% to $20.6 million in 2024, then skyrocketed by 213.71% to $64.7 million in 2025.
  • The last three reported values for Receivables Refunds were $64.7 million (Q4 2025), $69.0 million (Q3 2025), and $48.6 million (Q2 2025) per Business Quant data.